The global heparin market is estimated to grow at a CAGR of around 3% during the forecast period. The major factors contributing to the growth of the market include a significant rise in the number of venous thromboembolism and cardiovascular disorders such as coronary heart disease and heart attack. Heparin is an anticoagulant or a blood thinner used to prevent blood clots in the patients suffering from a heart attack, and strokes. It is an injectable drug used generally before the treatment of surgical procedures in order to reduce the risk of damage to veins and arteries. It is used for the treatment of heart diseases, injuries and other emergency medication in which blood supply to the heart is suddenly stopped.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/heparin-market

The pharmaceuticals companies are continuously working on the treatment and development of drugs associated with blood clotting and cardiovascular disease. For instance, in November 2019, Fresenius Kabi AG announced its launch of new heparin sodium injection Simplest which is ready to administer prefilled syringe used for the treatment of venous thromboembolism and pulmonary embolism. It is an anticoagulant and can also be used for the treatment of clotting in arterial and cardiac surgery. Further, in April 2019, B. Braun Medical Inc. announced its launch of Heparin Sodium Injection, USP. It is FDA approved and first of its kind syringe with attached needle for subcutaneous and intravenous use. It is designed with an aim to provide their patients with a better treatment experience with reduced risk of errors and expanding its product portfolio in the US in the medical field.

A Full Report of Heparin Market is Available at: https://www.omrglobal.com/industry-reports/fungicide-market

The global heparin market is segmented based on the product, route of administration and application. Based on the product, the market is classified into unfractionated heparin, low molecular weight heparin and ultra-low molecular weight heparin. Based on the route of administration, the market is classified into intravenous and subcutaneous. Based on the application, the market is classified into atrial fibrillation & heart attack, coronary heart disease, pulmonary embolism, deep vein thrombosis and others.
Deep vein thrombosis is anticipated to hold a significant share in the market in 2018. Deep vein thrombosis can be caused due to sports injuries, surgeries injuries veins which result in a medical condition in which normal blood clotting to a wound and breakdown of blood clotting has an imbalance in it. Heparin is used to prevent blood clotting or growing the existing blood clot. According to the report, every year more than 500,000 people suffer from sports injuries or accidents.


Heparin Market Segmentation
Global Heparin Market by Product
• Unfractionated Heparin
• Low molecular weight Heparin (LMWH)
• Ultra-Low Molecular Weight Heparin (ULMWH)


Global Heparin Market by Route of Administration
• Intravenous
• Subcutaneous


Global Heparin Market by Application
• Atrial Fibrillation & Heart Attack
• Coronary Artery Disease
• Pulmonary Embolism(PE)
• Deep Vein Thrombosis (DVT)
• Others (Stroke)


Heparin Market – Segment by Region
North America
• United States
• Canada

Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World
• Latin America
• Middle East and Africa

Company Profiles
B Barun Melsungen AG
Baxter International Inc.
Eisai Co. Ltd.
F. Hoffman-La Roche Ltd.
Fresenius Kabi AG
GlaxoSmithKline plc
Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
Hikma Pharmaceuticals PLC
Leo Pharma A/S
Mylan N.V.
Nanjing Jianyou Biochemical Pharmaceutical Co. Ltd.
Novartis AG
Opocrin S.P.A
Pfizer Inc.
Sanofi S.A.
Syntex S.A.


For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/heparin-market

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +1 646-755-7667, +91 780-304-0404